A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session8ad3969494252f413d09f732adb5b3425a9e4c54): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Swedish Porphyria Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

img

Global Swedish Porphyria Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Swedish Porphyria Therapeutics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyrias.
Swedish Porphyria Therapeutics report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swedish Porphyria Therapeutics market is projected to reach US$ 56 million in 2033, increasing from US$ 49 million in 2022, with the CAGR of 1.8% during the period of 2023 to 2033. Demand from Hospital and Pharmacy are the major drivers for the industry.
Panhematin (hemin) is a medication used to treat acute porphyria, a rare genetic disorder that affects heme production. Its effectiveness in managing acute porphyria attacks and reducing symptoms has driven market growth. The rarity of the condition and limited treatment options contribute to its niche status. However, challenges include the need for careful monitoring and potential side effects. The market competition is relatively small, as Panhematin remains a specialized therapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Swedish Porphyria Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Recordati Rare Diseases
Segment by Type
350mg
313mg

Segment by Application


Hospital
Pharmacy
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Swedish Porphyria Therapeutics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Swedish Porphyria Therapeutics introduction, etc. Swedish Porphyria Therapeutics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Swedish Porphyria Therapeutics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Swedish Porphyria Therapeutics
1.1 Swedish Porphyria Therapeutics Market Overview
1.1.1 Swedish Porphyria Therapeutics Product Scope
1.1.2 Swedish Porphyria Therapeutics Market Status and Outlook
1.2 Global Swedish Porphyria Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Swedish Porphyria Therapeutics Market Size by Region (2018-2033)
1.4 Global Swedish Porphyria Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Swedish Porphyria Therapeutics Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Swedish Porphyria Therapeutics Market Size (2018-2033)
1.6.1 North America Swedish Porphyria Therapeutics Market Size (2018-2033)
1.6.2 Europe Swedish Porphyria Therapeutics Market Size (2018-2033)
1.6.3 Asia-Pacific Swedish Porphyria Therapeutics Market Size (2018-2033)
1.6.4 Latin America Swedish Porphyria Therapeutics Market Size (2018-2033)
1.6.5 Middle East & Africa Swedish Porphyria Therapeutics Market Size (2018-2033)
2 Swedish Porphyria Therapeutics Market by Type
2.1 Introduction
2.1.1 350mg
2.1.2 313mg
2.2 Global Swedish Porphyria Therapeutics Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Swedish Porphyria Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Swedish Porphyria Therapeutics Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Swedish Porphyria Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Swedish Porphyria Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Swedish Porphyria Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Swedish Porphyria Therapeutics Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Swedish Porphyria Therapeutics Revenue Breakdown by Type (2018-2033)
3 Swedish Porphyria Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Pharmacy
3.2 Global Swedish Porphyria Therapeutics Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Swedish Porphyria Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Swedish Porphyria Therapeutics Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Swedish Porphyria Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Swedish Porphyria Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Swedish Porphyria Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Swedish Porphyria Therapeutics Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Swedish Porphyria Therapeutics Revenue Breakdown by Application (2018-2033)
4 Swedish Porphyria Therapeutics Competition Analysis by Players
4.1 Global Swedish Porphyria Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swedish Porphyria Therapeutics as of 2022)
4.3 Date of Key Players Enter into Swedish Porphyria Therapeutics Market
4.4 Global Top Players Swedish Porphyria Therapeutics Headquarters and Area Served
4.5 Key Players Swedish Porphyria Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Swedish Porphyria Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Recordati Rare Diseases
5.1.1 Recordati Rare Diseases Profile
5.1.2 Recordati Rare Diseases Main Business
5.1.3 Recordati Rare Diseases Swedish Porphyria Therapeutics Products, Services and Solutions
5.1.4 Recordati Rare Diseases Swedish Porphyria Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Recordati Rare Diseases Recent Developments
6 North America
6.1 North America Swedish Porphyria Therapeutics Market Size by Country (2018-2033)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Swedish Porphyria Therapeutics Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Swedish Porphyria Therapeutics Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Swedish Porphyria Therapeutics Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Swedish Porphyria Therapeutics Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Swedish Porphyria Therapeutics Market Dynamics
11.1 Swedish Porphyria Therapeutics Industry Trends
11.2 Swedish Porphyria Therapeutics Market Drivers
11.3 Swedish Porphyria Therapeutics Market Challenges
11.4 Swedish Porphyria Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Swedish Porphyria Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Swedish Porphyria Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Swedish Porphyria Therapeutics Market Size Share by Region (2018-2023)
Table 4. Global Swedish Porphyria Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Swedish Porphyria Therapeutics Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Swedish Porphyria Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Swedish Porphyria Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Swedish Porphyria Therapeutics Revenue Market Share by Type (2018-2023)
Table 9. Global Swedish Porphyria Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Swedish Porphyria Therapeutics Revenue Market Share by Type (2024-2033)
Table 11. North America Swedish Porphyria Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Swedish Porphyria Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Swedish Porphyria Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Swedish Porphyria Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Swedish Porphyria Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Swedish Porphyria Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Swedish Porphyria Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Swedish Porphyria Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Swedish Porphyria Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Swedish Porphyria Therapeutics Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Swedish Porphyria Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Swedish Porphyria Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Swedish Porphyria Therapeutics Revenue Market Share by Application (2018-2023)
Table 24. Global Swedish Porphyria Therapeutics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Swedish Porphyria Therapeutics Revenue Market Share by Application (2024-2033)
Table 26. North America Swedish Porphyria Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Swedish Porphyria Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Swedish Porphyria Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Swedish Porphyria Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Swedish Porphyria Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Swedish Porphyria Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Swedish Porphyria Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Swedish Porphyria Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Swedish Porphyria Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Swedish Porphyria Therapeutics Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Swedish Porphyria Therapeutics Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Swedish Porphyria Therapeutics Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swedish Porphyria Therapeutics as of 2022)
Table 39. Date of Key Players Enter into Swedish Porphyria Therapeutics Market
Table 40. Global Swedish Porphyria Therapeutics Key Players Headquarters and Area Served
Table 41. Swedish Porphyria Therapeutics Product Solution and Service
Table 42. Global Swedish Porphyria Therapeutics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Recordati Rare Diseases Basic Information List
Table 45. Recordati Rare Diseases Description and Business Overview
Table 46. Recordati Rare Diseases Swedish Porphyria Therapeutics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Swedish Porphyria Therapeutics Business of Recordati Rare Diseases (2018-2023)
Table 48. Recordati Rare Diseases Recent Developments
Table 49. North America Swedish Porphyria Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 50. North America Swedish Porphyria Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 51. Europe Swedish Porphyria Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 52. Europe Swedish Porphyria Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 53. Asia-Pacific Swedish Porphyria Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia-Pacific Swedish Porphyria Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia-Pacific Swedish Porphyria Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 56. Asia-Pacific Swedish Porphyria Therapeutics Market Share by Region (2018-2023)
Table 57. Asia-Pacific Swedish Porphyria Therapeutics Market Share by Region (2024-2033)
Table 58. Latin America Swedish Porphyria Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 59. Latin America Swedish Porphyria Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 60. Latin America Swedish Porphyria Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 61. Middle East & Africa Swedish Porphyria Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East & Africa Swedish Porphyria Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East & Africa Swedish Porphyria Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 64. Swedish Porphyria Therapeutics Market Trends
Table 65. Swedish Porphyria Therapeutics Market Drivers
Table 66. Swedish Porphyria Therapeutics Market Challenges
Table 67. Swedish Porphyria Therapeutics Market Restraints
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Swedish Porphyria Therapeutics Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Swedish Porphyria Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Swedish Porphyria Therapeutics Market Share by Regions: 2022 VS 2033
Figure 4. Global Swedish Porphyria Therapeutics Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Swedish Porphyria Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Swedish Porphyria Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Swedish Porphyria Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Swedish Porphyria Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Swedish Porphyria Therapeutics Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of 350mg
Figure 11. Global 350mg Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of 313mg
Figure 13. Global 313mg Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Swedish Porphyria Therapeutics Market Size Share by Type: 2022 & 2033
Figure 15. North America Swedish Porphyria Therapeutics Revenue Market Share by Type (2018-2033)
Figure 16. Europe Swedish Porphyria Therapeutics Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Swedish Porphyria Therapeutics Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Swedish Porphyria Therapeutics Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Swedish Porphyria Therapeutics Revenue Market Share by Type (2018-2033)
Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Pharmacy Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Global Swedish Porphyria Therapeutics Market Size Share by Application: 2022 & 2033
Figure 23. North America Swedish Porphyria Therapeutics Revenue Market Share by Application (2018-2033)
Figure 24. Europe Swedish Porphyria Therapeutics Revenue Market Share by Application (2018-2033)
Figure 25. Asia-Pacific Swedish Porphyria Therapeutics Revenue Market Share by Application (2018-2033)
Figure 26. Latin America Swedish Porphyria Therapeutics Revenue Market Share by Application (2018-2033)
Figure 27. Middle East and Africa Swedish Porphyria Therapeutics Revenue Market Share by Application (2018-2033)
Figure 28. Swedish Porphyria Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players Swedish Porphyria Therapeutics Market Share in 2022
Figure 30. North America Swedish Porphyria Therapeutics Market Share by Country (2018-2033)
Figure 31. the United States Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 32. Canada Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 33. Germany Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 34. France Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 35. U.K. Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 36. Italy Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 37. Russia Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 38. Nordic Countries Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Swedish Porphyria Therapeutics Market Share by Region (2018-2033)
Figure 40. China Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 41. Japan Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 42. South Korea Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 44. India Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 45. Australia Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 46. Latin America Swedish Porphyria Therapeutics Market Share by Country (2018-2033)
Figure 47. Mexico Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 48. Brazil Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Swedish Porphyria Therapeutics Market Share by Country (2018-2033)
Figure 50. Turkey Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 52. UAE Swedish Porphyria Therapeutics Market Size (2018-2033) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries